Aurinia Pharmaceuticals Inc – Filings and Transcripts

NASDAQ: AUPH
Share price (6/2/26): $15.39
Market cap (6/2/26): $2.000 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Third party tender offer – amended

Third party tender offer

Registration of securities for employees

Registration of securities for employees

Automatic shelf registration

Ownership Filter

Tang Kevin, Tang Capital Management LLC

Robertson Stephen P.

Hearne Michael S

News Filter

Completion of Acquisition or Disposition of Assets, Financial Statements or Exhibits

Reports Financial Results for the Three Months Ended March 31, 2026 and Provides Update on Recent Business Progress

To Acquire Kezar Life Sciences for $6.955 in Cash Per Share Plus a Contingent Value Right

Announces Management Transition

Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress

Proxies Filter

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Appointment of agent for service of process and undertaking

Notice of effectiveness

Appointment of agent for service of process and undertaking